Of interest, bortezomib was reported to repress the transcription of BMI1 in the side population of mantle cell lymphoma cells23 and reduce the levels of mono-ubiquitination of histone H2A at Lysine 119 (uH2A)24. Here, BMI1 is linked to mantle cell lymphoma.